Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 39Thoracic 4Plasma cell 4Other neoplasm 3Other hematologic neoplasm 3Lymphoid 3Dermatologic 3Gynecologic 2Genitourinary 2Breast 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Anemia 1

Interventions

Epoetin Alfa 6venetoclax 1trametinib 1stinging nettle lectin 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1peppermint oil 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1dehydroftorafur 1darolutamide 1dacomitinib 1dabrafenib 1copanlisib 1cobimetinib 1cabozantinib 1cabazitaxel 1bicalutamide 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × Darbepoetin alfa × Breast × Clear all
NCT00120692 2007-12-24

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Amgen

Phase 2 Completed
BreastClassical hematology

Anemia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡